Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Kindstar Globalgene Technology, Inc. ( (HK:9960) ) is now available.
Kindstar Globalgene Technology, Inc. reported a decrease in revenue and a significant net loss for the first half of 2025, attributed to external market pressures, increased operating costs, and losses from recent acquisitions. The company’s gross profit margin also declined due to these factors, impacting its financial performance and highlighting the challenges faced in maintaining profitability amidst a competitive market environment.
The most recent analyst rating on (HK:9960) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Kindstar Globalgene Technology, Inc. stock, see the HK:9960 Stock Forecast page.
More about Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. operates in the biotechnology industry, focusing on providing specialized diagnostic testing services. The company is known for its advanced laboratory services and has been expanding its market presence through acquisitions.
Average Trading Volume: 1,052,242
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.55B
See more data about 9960 stock on TipRanks’ Stock Analysis page.